Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 8, Issue 4 (2019)

Risk assessment and uncertainty appraisal for quantification of Aripiprazole and lamotrigine in combination: A neoteric validation approach

Author(s):
Krishna Jadav and Rajashree Mashru
Abstract:
Risk profile and uncertainty approximation are two prime and important parameters that need to be accepted for the evolution of the pharmaceutical process to obtain reliable results. The ordinary method validation process needs to be extempore so, as to provide to a high level of assurance of method reliability to quantify the quality element of a drug product. Risk contour, combined standard uncertainty and expanded uncertainty in the analysis of Aripiprazole and Lamotrigine in the synthetic mixture were analysed by absorption correction method in this present research work. The cause-effect diagram was used to determine uncertainty parameters and to make it more accurate and precise method was validated in our laboratory as per the ICH guidelines. Whilst evaluate the results of validation, a calibration model was established by Levene’s test. In uncertainty, the major contribution is owing to sample concentration and mass of the sample. This present research work distinctly illustrates the application of the theoretical concept of calibration model tests, relative bias, risk analysis and uncertainty in the method used for analysis in drug invention activity.
Pages: 538-548  |  120 Views  5 Downloads
How to cite this article:
Krishna Jadav, Rajashree Mashru. Risk assessment and uncertainty appraisal for quantification of Aripiprazole and lamotrigine in combination: A neoteric validation approach. Pharma Innovation 2019;8(4):538-548.
The Pharma Innovation Journal